News & Press Releases
PRESS RELEASE
Melior Pharmaceuticals Announces Execution of License Agreement for Armesocarb by Adhera Therapeutics
July 29, 2021
READ MORE DOWNLOAD PDFPRESS RELEASE
Melior Pharmaceuticals Announces Entry Into "Letter-of-Intent" for the Acquisition of Armescarb by Adhera Therapeutics
June 7, 2021
READ MORE DOWNLOAD PDFPRESS RELEASE
Melior Pharmaceuticals Receives IND Clearance from US FDA for COVID-19 Therapeutic
March 9, 2021
READ MORE DOWNLOAD PDFPRESS RELEASE
Melior Pharmaceuticals Announces Grant Award for Initiating COVID-19 Clinical Trial
September 15, 2020
READ MORE DOWNLOAD PDFPRESS RELEASE
Melior Pharmaceuticals Announces Positive Results in Phase 2B Study with Tolimidone for Type 2 Diabetes
May 14, 2019
READ MORE DOWNLOAD PDFPRESS RELEASE
Melior Pharmaceuticals Enrolls Last Subject in Phase 2b Study with Tolimidone for Type 2 Diabetes
October 16, 2018
READ MORE DOWNLOAD PDFPRESS RELEASE
Melior Pharmaceuticals Initiates Phase 2B Study with MLR-1023 for Type 2 Diabetes
October 3, 2017
READ MORE DOWNLOAD PDFPRESS RELEASE
Melior Pharmaceuticals Announces Positive Phase 2A Results in Type 2 Diabetes Study
June 13, 2016
READ MORE DOWNLOAD PDFPRESS RELEASE
Melior Discovery Announces Spinout of Melior Pharmaceuticals II, LLC
May 10, 2016
READ MORE DOWNLOAD PDFPRESS RELEASE
Melior Pharmaceuticals Achieves Partnership Milestone with Bukwang Pharmaceutical Co.
March 15, 2016
READ MORE DOWNLOAD PDFPRESS RELEASE
Melior Discovery Receives Patent Approval from U.S. Patent and Trademark Office for New Parkinson's Disease Drug Candidate
June 10, 2015
READ MORE DOWNLOAD PDFPRESS RELEASE
Melior Pharmaceuticals Initiates Phase 2 Study with MLR-1023 for Type 2 Diabetes
March 3, 2015
READ MORE DOWNLOAD PDFPRESS RELEASE
Melior Discovery Awarded SBIR Grant for Studying MLR-1023 Mechanism of Action
December 11, 2014
READ MORE DOWNLOAD PDFPRESS RELEASE
Melior Pharmaceuticals Receives First Performance Milestone Payment from Bukwang Pharmaceutical
October 7, 2014
READ MORE DOWNLOAD PDFPRESS RELEASE
Melior Licenses Novel Diabetes Drug to Bukwang Pharmaceutical Co.
December 4, 2013
READ MORE DOWNLOAD PDFPRESS RELEASE
Melior Announces Two Publications Describing New Therapeutic Opportunity in Diabetes
April 17, 2012
READ MORE DOWNLOAD PDF